People with ADHD face a significantly higher risk of dying early, according to a sweeping new meta-analysis. The study of 16 million people found ADHD was tied to a 71% increased risk of all-cause mortality, with elevated risks for suicide, injury, and natural causes. On the brighter side, ADHD medication use was associated with a 25% lower mortality risk.
A large-scale systematic review and meta-analysis published in JAMA Network Open has found that people with ADHD face a dramatically higher risk of early death compared to those without the condition. Analyzing data from 19 studies covering nearly 16 million participants, researchers from University College London found that ADHD was associated with a 71% increased risk of all-cause mortality — with elevated risks spanning suicide, unintentional or intentional injury, and natural causes.
The researchers point to several potential pathways: ADHD's core traits like impulsivity and risk-taking may fuel injury risk, while co-occurring conditions like depression can raise suicide risk. Behaviors such as smoking and alcohol use, along with barriers to healthcare access, may drive up natural-cause mortality. Encouragingly, ADHD medication use was linked to a 25% lower risk of all-cause mortality — though this finding was based on only three studies and should be interpreted with caution.
By the Numbers:
Why it matters: ADHD is often diagnosed late or not at all — especially in adults — meaning many people miss out on potentially life-saving treatment. These findings make a strong case for expanding access to timely ADHD diagnosis and care.
